← Back to All Calculators
Oncology
Revised International Prognostic Index (R-IPI) for DLBCL
Prognostic stratification for Diffuse Large B-Cell Lymphoma
R-IPI Adverse Factors (1 point each)
+1 pt
+1 pt
+1 pt
+1 pt
+1 pt
CNS IPI Additional Risk Factors
CNS factor
R-IPI Score
0
/ 5
R-IPI Prognostic Assessment
R-IPI Score
—
R-IPI Category
—
Estimated 4-Year OS
—
Original IPI Category
—
CNS Risk Assessment
—
Standard Treatment Approach
—
R-IPI Prognostic Reference
| R-IPI Score | Category | 4-Year OS | Recommended Approach |
|---|---|---|---|
| 0 | Very Good | ~94% | R-CHOP ×6 cycles |
| 1–2 | Good | ~79% | R-CHOP ×6 cycles |
| 3–5 | Poor | ~55% | R-CHOP ±dose intensification; consider clinical trial |
